KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Accounts Payables (2020 - 2025)

Clover Health Investments' Accounts Payables history spans 6 years, with the latest figure at $36.2 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 4.77% year-over-year to $36.2 million; the TTM value through Dec 2025 reached $36.2 million, up 4.77%, while the annual FY2025 figure was $36.2 million, 4.77% up from the prior year.
  • Accounts Payables reached $36.2 million in Q4 2025 per CLOV's latest filing, up from $32.9 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $47.5 million in Q1 2023 to a low of $11.1 million in Q4 2021.
  • Average Accounts Payables over 5 years is $25.6 million, with a median of $25.8 million recorded in 2021.
  • Peak YoY movement for Accounts Payables: skyrocketed 160.03% in 2023, then crashed 57.79% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $11.1 million in 2021, then increased by 28.83% to $14.3 million in 2022, then surged by 160.03% to $37.2 million in 2023, then decreased by 7.05% to $34.6 million in 2024, then grew by 4.77% to $36.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Accounts Payables are $36.2 million (Q4 2025), $32.9 million (Q3 2025), and $34.0 million (Q2 2025).